ANNIE WALKER: Open Payments
NPI 1952860959 · ALBANY, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,010 in 73 payments from 21 companies in 2025. Trend: 2023 $1,539 · 2024 $1,607 · 2025 $2,010
Food & beverage: $1,997Entertainment: $14
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $281 |
| Gilead Sciences, Inc. | 2 | $241 |
| Amgen Inc. | 11 | $229 |
| AstraZeneca Pharmaceuticals LP | 4 | $188 |
| PFIZER INC. | 7 | $158 |
| Sumitomo Pharma America, Inc. | 5 | $151 |
| Lilly USA, LLC | 8 | $126 |
| Corcept Therapeutics | 1 | $122 |
| Novo Nordisk Inc | 6 | $114 |
| Exact Sciences Corporation | 1 | $90 |
Products named: Kerendia, OTEZLA, BREZTRI, GEMTESA, MOUNJARO, Biktarvy, Korlym, Epclusa.
Industry payments across GA — which companies pay providers there.
